There was news put out by Biocurex some time back that explained that licensing deals will shape the future of Biocurex and it is important to do this correctly.
I also agree that Abbott has got to be happy with Recaf.
Further.....Abbott is the name that the medical community trusts and anything going up against the PSA test would have a hard time breaking into the market for many reasons.
Remember Ross Perrot running for President. He never really got a fair shake because he did not belong to either party "A" or party "B". He was an independent. The same goes for the medical community. Biocurex got with Abbott because they new the rules of the game.
Regardless of the other potential agreements out there...Biocurex will not cross Abbott.
Merovingian, your theory is certainly plausible, but there's just no way to tell whether it is likely.
I think it is equally probable (given what we on the outside know) that one or more licensing agreements with other parties may be in negotiation now. Consider the time it took to negotiate the Abbott deal. They probably began engaging seriously with Abbott at the ISOBM in July 2004, and only announced the deal in April 2005. So another licensing announcement at this point is not necessarily "overdue."
News 
Market Data 
Discover 
